DA
Dillon & Associates Portfolio holdings
AUM
$737M
This Quarter Return
+1.67%
1 Year Return
+16.41%
3 Year Return
+121.33%
5 Year Return
+190.29%
10 Year Return
+499.62%
AUM
$218M
AUM Growth
+$218M
(+0.99%)
Cap. Flow
-$574K
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
43.02%
Holding
70
New
1
Increased
21
Reduced
36
Closed
–
Top Buys
| 1 |
Starbucks
SBUX
|
$553K |
| 2 |
Danaher
DHR
|
$393K |
| 3 |
CVS Health
CVS
|
$282K |
| 4 |
O'Reilly Automotive
ORLY
|
$251K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$213K |
Top Sells
| 1 |
Boston Beer
SAM
|
$855K |
| 2 |
SRCL
Stericycle Inc
SRCL
|
$508K |
| 3 |
Novartis
NVS
|
$324K |
| 4 |
Schlumberger
SLB
|
$243K |
| 5 |
Qualcomm
QCOM
|
$228K |
Sector Composition
| 1 | Healthcare | 24.17% |
| 2 | Technology | 17.37% |
| 3 | Consumer Staples | 16.72% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Industrials | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amgen
AMGN
$155B
| $568K | 0.26% |
3,739
| – | – |
|
52
Core Laboratories
CLB
$540M
| $539K | 0.25% |
4,350
| – | – |
|
|
53
CVS Health
CVS
$92.8B
| $511K | 0.23% |
5,325
+2,940
| +123% | +$282K |
|
54
Cisco
CSCO
$274B
| $439K | 0.2% |
15,123
| – | – |
|
55
Genuine Parts
GPC
$19.4B
| $432K | 0.2% |
4,280
-175
| -4% | -$17.7K |
|
56
Biogen
BIIB
$19.4B
| $407K | 0.19% |
1,680
+245
| +17% | +$59.4K |
|
|
ESRX
57
DELISTED
Express Scripts Holding Company
ESRX
| $405K | 0.19% |
5,325
+580
| +12% | +$44.1K |
|
58
Microsoft
MSFT
$3.77T
| $401K | 0.18% |
7,861
-160
| -2% | -$8.16K |
|
59
Kraft Heinz
KHC
$33.1B
| $328K | 0.15% |
3,725
| – | – |
|
60
Eaton
ETN
$136B
| $285K | 0.13% |
4,756
-600
| -11% | -$36K |
|
61
Target
TGT
$43.6B
| $273K | 0.13% |
3,900
-250
| -6% | -$17.5K |
|
62
AT&T
T
$209B
| $247K | 0.11% |
5,739
+200
| +4% | +$8.61K |
|
63
IBM
IBM
$227B
| $243K | 0.11% |
1,600
| – | – |
|
64
Verizon
VZ
$186B
| $241K | 0.11% |
4,305
| – | – |
|
65
Chevron
CVX
$324B
| $234K | 0.11% |
2,233
| – | – |
|
66
Emerson Electric
EMR
$74.3B
| $232K | 0.11% |
4,457
-600
| -12% | -$31.2K |
|
67
Gilead Sciences
GILD
$140B
| $230K | 0.11% |
2,775
-250
| -8% | -$20.7K |
|
68
Altria Group
MO
$113B
| $228K | 0.1% |
3,307
-50
| -1% | -$3.45K |
|
69
Comerica
CMA
$9.07B
| $211K | 0.1% |
+5,157
| New | +$211K |
|
|
GCVRZ
70
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $3K | ﹤0.01% |
10,660
| – | – |
|